Literature DB >> 9854124

Inotropic therapy for heart failure.

L W Stevenson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9854124     DOI： 10.1056/NEJM199812173392511

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Rational use of inotropic therapy in heart failure.

Authors:  G M Felker; C M O'Connor
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

Review 2.  Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.

Authors:  T H LeJemtel
Journal:  Curr Cardiol Rep       Date:  1999-05       Impact factor: 2.931

Review 3.  Targeting calcium cycling proteins in heart failure through gene transfer.

Authors:  Federica del Monte; Roger J Hajjar
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

Review 4.  Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups.

Authors:  Shigetake Sasayama
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Recombinant human GHRH(1-44)NH2: clinical utility and therapeutic development program.

Authors:  M R Ehlers
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

6.  Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a.

Authors:  S E Harding; U Schmidt; T Matsui; Z B Kang; G W Dec; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

7.  Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.

Authors:  F del Monte; E Williams; D Lebeche; U Schmidt; A Rosenzweig; J K Gwathmey; E D Lewandowski; R J Hajjar
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

Review 8.  Pharmacological management of chronic heart failure in adults: a review of the literature.

Authors:  Richard Auty
Journal:  Malawi Med J       Date:  2004-03       Impact factor: 0.875

Review 9.  Clinical characteristics of vesnarinone.

Authors:  Arthur M Feldman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  Management of end-stage heart failure: a perspective on the Arab Gulf states.

Authors:  Waleed Al Habeeb; Garrick C Stewart; Gilbert H Mudge
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.